Skip to main content

Chronic Granulomatous Disease clinical trials at UCSF

1 in progress, 0 open to eligible people

Showing trials for
  • Patients Treated for Chronic Granulomatous Disease (CGD) Since 1995

    Sorry, accepting new patients by invitation only

    Chronic granulomatous disease (CGD) is an inherited immune system abnormality in which bone marrow transplantation (BMT) has been shown to be curative. However the risks of transplantation are high and not all patients with CGD may need to undergo this high risk procedure. This study will determine the long term medical condition and daily functioning of participants with CGD after a transplant and if possible, compare these results to participants who do not undergo a transplant.

    San Francisco, California and other locations

Our lead scientists for Chronic Granulomatous Disease research studies include .

Last updated: